The U.S. Food and Drug Administration (FDA) has granted full approval to a new drug for Alzheimer's disease. The drug Leqembi had already received provisional approval in January in an accelerated procedure. It targets a protein called beta-amyloid, which causes deposits in the brains of Alzheimer's patients. While the drug does not cure Alzheimer's, it can apparently slow the progression of their dementia. The price of the treatment was initially set at the equivalent of about 24,000 euros per year.
Noninvasive neurostimulation is a promising technique that could one day provide treatment for dementia. For now, clinicians continue to stress the importance of preventive measures.
Update am Morgen: Merkels Erbe zdf.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zdf.de Daily Mail and Mail on Sunday newspapers.
Demenzerkrankungen bedeuten für die Betroffenen, aber auch für Angehörige und Pflegepersonal eine große Belastung. In Hessen gibt es vielfältige Unterstützungsangebote.
Bevor die Plaques kommen: Veränderte Nervenzellen deuten auf Alzheimer-Demenz hin bionity.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bionity.com Daily Mail and Mail on Sunday newspapers.